| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rosiglitazone | FAERS: 2 | US FAERS | |
| 2 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 3 | Bosentan | FAERS: 1 | US FAERS | |
| 4 | Everolimus | FAERS: 1 | US FAERS | |
| 5 | Fondaparinux | FAERS: 1 | US FAERS | |
| 6 | NuvaRing | FAERS: 1 | US FAERS | |
| 7 | Valsartan | FAERS: 1 | US FAERS | |
| 8 | Alosenn | OFFSIDES | ||
| 9 | Atropine | OFFSIDES | ||
| 10 | Cetirizine | OFFSIDES | ||
| 11 | Epinephrine | OFFSIDES | ||
| 12 | Formoterol Fumarate | OFFSIDES | ||
| 13 | Nitrates | OFFSIDES | ||
| 14 | Ranitidine | OFFSIDES | ||
| 15 | Terbinafine | OFFSIDES | ||
| 16 | Trimetazidine | OFFSIDES | ||
| 17 | epalrestat | OFFSIDES | ||
| 18 | isosorbide-5-mononitrate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.